Current Patents Gazette is a rapid competitive intelligence service covering innovation in the pharmaceutical industry. It provides full coverage of new patents and applications published during the previous seven days, expertly classified, analyzed and put into context to provide quick and easy access to those areas important to your work.
Key pharmaceutical patent documents published each week from around the world, are compiled from a wide range of sources to produce Current Patents Gazette.
With Current Patents Gazette, you can:
- Read PCT (Patent Co-operation Treaty) applications , published every Thursday by the World Intellectual Property Organisation (WIPO), European and US PreGrant published applications and issued patents.
- Access informal researched comments on selected UK initial "A0" applications.
- Explore all European granted patents with value-added content in our DOLPHIN database.
Why choose Current Patents Gazette?
- Weekly highlights focusing on patent-related issues making the headlines, noteworthy new applications, and litigation and legislation affecting the industry.
- Analysis and comments to indicate where all new inventions fit into the applicants' existing portfolios and innovation profiles.
- Electronic formats to suit you. The Gazette is supplied as a convenient PDF file or in database format, with links to source documents in electronic versions.
- Section A: New Compounds PDF . Covers all new applications describing novel compounds and derivatives with pharmaceutical utility. An analysis of the invention is provided, including its origin and how it relates to established drug candidates or research work, putting the discovery into its true commercial context. Because these new compound applications are especially important, all cases within Section A are presented with accompanying images of the full front page text of the specification, in order to provide at a glance the chemical structure of each compound as well as the official abstract, names of inventors and technical details.
- Section B: New Uses, Formulations & Methods of Treatment PDF. As candidates progress into development they often become the subject of further innovation. The claim types vary considerably, and include such aspects as new methods of treatment and formulations, alongside ancillary technology not directly related to therapy, such as diagnostics. Analysis of these new use and formulation cases can offer insights into which compounds are progressing towards commercial exploitation, in which formulations and for which precise indications.
- Section C: Chemical Processes and Combinatorial Technology PDF . Advances in chemical technology are another good indicator of a company's development activity and such cases are covered in Section C. Study of these scale-up cases can point to pipeline candidates being prepared for clinical trials and ultimately commercial production.
- Section D: Biotechnology PDF Biotechnology is the most rapidly expanding and sometimes most controversial area in the pharmaceutical industry today. The latest advances in transgenics and cloning, viruses, enzyme and polypeptide compounds and immunology are all presented in Section D. Collaborations between companies and non-industrial researchers are also highlighted to provide you with the cutting edge in competitive intelligence.
- Section E: Devices and Equipment PDF. Section E is the first of two device-orientated sections covering advances in mechanical technology linked to the pharmaceutical and biotech sectors. Applications relating to analytical and manufacturing apparatus are featured alongside drug delivery devices, packaging and developments in software related to patient administration and remote diagnosis.
Next Steps
NEWS HIGHLIGHTS
DIRECTOR, CURRENT AWARENESS
Peter Steele
Tel: +44 20 7433 4749
Customer Support
Tel: +44 20 7433 4000